Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia

Background: Biomarkers predicting the risk of VL treatment failure and relapse in VL/HIV coinfected patients are needed. Nested within a two-site clinical trial in Ethiopia (2011–2015), we conducted an exploratory study to assess whether (1) levels of Leishmania antigenuria measured at VL diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: van Griensven, Johan, Mengesha, Bewketu, Mekonnen, Tigist, Fikre, Helina, Takele, Yegnasew, Adem, Emebet, Mohammed, Rezika, Ritmeijer, Koert, Vogt, Florian, Adriaensen, Wim, Diro, Ermias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884955/
https://www.ncbi.nlm.nih.gov/pubmed/29651411
http://dx.doi.org/10.3389/fcimb.2018.00094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5884955/
https://www.ncbi.nlm.nih.gov/pubmed/29651411
http://dx.doi.org/10.3389/fcimb.2018.00094

Ejemplares similares